Article info

Detection of the CD56+/CD45− immunophenotype by flow cytometry in neuroendocrine malignancies
Free
  1. Correspondence to:
 Dr R C W Wong, Division of Immunology, Queensland Health Pathology Services, Royal Brisbane Hospital, Herston 4029, Queensland, Australia;
 richard_wong{at}health.qld.gov.au
View Full Text

Citation

Bryson GJ, Lear D, Williamson R, et al
Detection of the CD56+/CD45− immunophenotype by flow cytometry in neuroendocrine malignancies

Publication history

  • Accepted February 4, 2002
  • First published July 1, 2002.
Online issue publication 
July 01, 2002
  •  
    Detection of the CD56+/CD45- immunophenotype by flow cytometry in neuroendocrine malignancies
    GJ Bryson, D Lear, R Williamson, RCW Wong
     

    Publisher's Correction
    Please note that the quotation from column 1, page 535 should be the second sentence of the first paragraph; also there was an error in this sentence. CD59 should have read CD56. The corrected sentence is shown here:

    CD56 is expressed on a variety of cell types including natural killer cells, certain T cell subsets, large granular lymphocyte leukaemias, some myeloid leukaemias, and cells of neural origin.
     

    The error is much regretted

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.